214 related articles for article (PubMed ID: 28834576)
1. Mammalian target of rapamycin as a therapeutic target in osteoporosis.
Shen G; Ren H; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Tang J; Liang D; Yao Z; Yang Z; Jiang X
J Cell Physiol; 2018 May; 233(5):3929-3944. PubMed ID: 28834576
[TBL] [Abstract][Full Text] [Related]
2. The l-Ser analog #290 promotes bone recovery in OP and RA mice.
Bahtiar A; Nakamura T; Kishida K; Katsura J; Nitta M; Ishida-Kitagawa N; Ogawa T; Takeya T
Pharmacol Res; 2011 Sep; 64(3):203-9. PubMed ID: 21605676
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin mediated bone formation is regulated by mTOR signaling.
Kim J; Jung Y; Sun H; Joseph J; Mishra A; Shiozawa Y; Wang J; Krebsbach PH; Taichman RS
J Cell Biochem; 2012 Jan; 113(1):220-8. PubMed ID: 21898543
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
Wang L; Zhang HY; Gao B; Shi J; Huang Q; Han YH; Hu YQ; Lu WG; Zhao ZJ; Liu BH; Jie Q; Yang L; Luo ZJ
Stem Cells Dev; 2017 Mar; 26(6):419-430. PubMed ID: 27917698
[TBL] [Abstract][Full Text] [Related]
5. Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts.
Wu H; Wu Z; Li P; Cong Q; Chen R; Xu W; Biswas S; Liu H; Xia X; Li S; Hu W; Zhang Z; Habib SL; Zhang L; Zou J; Zhang H; Zhang W; Li B
Stem Cell Reports; 2017 Jun; 8(6):1600-1616. PubMed ID: 28479301
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin promotes osteogenesis under inflammatory conditions.
Li X; Chang B; Wang B; Bu W; Zhao L; Liu J; Meng L; Wang L; Xin Y; Wang D; Tang Q; Zheng C; Sun H
Mol Med Rep; 2017 Dec; 16(6):8923-8929. PubMed ID: 28990080
[TBL] [Abstract][Full Text] [Related]
7. Evidence based anti-osteoporosis effects of Periplaneta americana L on osteoblasts, osteoclasts, vascular endothelial cells and bone marrow derived mesenchymal stem cells.
Huang YF; Li LJ; Gao SQ; Chu Y; Niu J; Geng FN; Shen YM; Peng LH
BMC Complement Altern Med; 2017 Aug; 17(1):413. PubMed ID: 28821253
[TBL] [Abstract][Full Text] [Related]
8. Energy Metabolism of Bone.
Motyl KJ; Guntur AR; Carvalho AL; Rosen CJ
Toxicol Pathol; 2017 Oct; 45(7):887-893. PubMed ID: 29096593
[TBL] [Abstract][Full Text] [Related]
9. Suppression of mTOR signaling pathway promotes bone marrow mesenchymal stem cells differentiation into osteoblast in degenerative scoliosis: in vivo and in vitro.
Wang Y; Yi XD; Li CD
Mol Biol Rep; 2017 Feb; 44(1):129-137. PubMed ID: 27888418
[TBL] [Abstract][Full Text] [Related]
10. Communication factors-promising targets in osteoporosis treatment.
Zhang Y; Liu P; Li J; Li K; Teng Y; Wang X; Li X
Curr Drug Targets; 2014 Feb; 15(2):156-63. PubMed ID: 23919828
[TBL] [Abstract][Full Text] [Related]
11. Conjugated linoleic acid prevents age-induced bone loss in mice by regulating both osteoblastogenesis and adipogenesis.
Lin G; Wang H; Dai J; Li X; Guan M; Gao S; Ding Q; Wang H; Fang H
Biochem Biophys Res Commun; 2017 Aug; 490(3):813-820. PubMed ID: 28647365
[TBL] [Abstract][Full Text] [Related]
12. Chronic High Dose Alcohol Induces Osteopenia via Activation of mTOR Signaling in Bone Marrow Mesenchymal Stem Cells.
Liu Y; Kou X; Chen C; Yu W; Su Y; Kim Y; Shi S; Liu Y
Stem Cells; 2016 Aug; 34(8):2157-68. PubMed ID: 27145264
[TBL] [Abstract][Full Text] [Related]
13. Autophagy as a target for glucocorticoid-induced osteoporosis therapy.
Shen G; Ren H; Shang Q; Qiu T; Yu X; Zhang Z; Huang J; Zhao W; Zhang Y; Liang D; Jiang X
Cell Mol Life Sci; 2018 Aug; 75(15):2683-2693. PubMed ID: 29427075
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast as a target of anti-osteoporotic treatment.
Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
[TBL] [Abstract][Full Text] [Related]
15. The Development of Molecular Biology of Osteoporosis.
Gao Y; Patil S; Jia J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360948
[TBL] [Abstract][Full Text] [Related]
16. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
17. The calcium-sensing receptor in bone metabolism: from bench to bedside and back.
Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML
Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
20. Pulsed electromagnetic fields inhibit osteoclast differentiation in RAW264.7 macrophages via suppression of the protein kinase B/mammalian target of rapamycin signaling pathway.
Lei Y; Su J; Xu H; Yu Q; Zhao M; Tian J
Mol Med Rep; 2018 Jul; 18(1):447-454. PubMed ID: 29749519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
